Targeted cholesterol-lowering therapy can prevent first heart attack or stroke in high-risk patients with diabetes CARDIOLOGIA DIABETOLOGIA FARMACOLOGIA HEALTH U.S. NEUROLOGIA RICERCA Targeted cholesterol-lowering therapy can prevent first heart attack or stroke in high-risk patients with diabetes Redazione 5 Aprile 2026 Mass General Brigham researchers found that the intensive cholesterol‑lowering therapy evolocumab reduced the risk of a first... Per saperne di più Maggiori informazioni su Targeted cholesterol-lowering therapy can prevent first heart attack or stroke in high-risk patients with diabetes
